Cargando…
Molecular Pathogenesis and Disease-modifying Therapies of Alzheimer’s Disease and Related Disorders
The deposition of amyloid β (Aβ) peptides as senile plaques and tau as neurofibrillary changes causes the hallmark neuropathological lesions of Alzheimer’s disease (AD), which are implicated in its pathogenesis and deemed as the prime target for disease-modifying therapies (DMTs). Aβ is produced by...
Autor principal: | Iwatsubo, Takeshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japan Medical Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358130/ https://www.ncbi.nlm.nih.gov/pubmed/35992282 http://dx.doi.org/10.31662/jmaj.2022-0079 |
Ejemplares similares
-
The past, present, and future of disease-modifying therapies for Alzheimer’s disease
por: SUZUKI, Kazushi, et al.
Publicado: (2017) -
Inflammation in Alzheimer's disease: relevance to pathogenesis and therapy
por: Zotova, Elina, et al.
Publicado: (2010) -
Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease
por: Guo, Tiantian, et al.
Publicado: (2020) -
Pathogenesis of Alzheimer’s disease
por: Swerdlow, Russell H
Publicado: (2007) -
Molecular Targets in Alzheimer's Disease: From Pathogenesis to Therapeutics
por: Cheng, Xuan, et al.
Publicado: (2015)